Submit

Thousand Oaks-based Atara Biotherapeutics has reached an agreement with the federal Food and Drug Administration that clears the way for the company to submit to the agency clinical trial data for its drug to treat a rare blood cancer. Atara has developed a drug platform comprised of a type of immune cell known as a […]